Penumbra (PEN) News
NYSE: PENHealth CareMedical/Dental InstrumentsUSD
319.12-0.89 (-0.28%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PEN news summary
We found 32 recent headlines mentioning Penumbra (PEN): 0 in the past week and 3 in the past 30 days, most often from Nasdaq, Seeking Alpha, PR Newswire. For price context, PEN is down 0.28% at $319.12. The most recent story, "Penumbra, Inc. Reports Third Quarter 2026 Revenue of $410.1 million", was published by Nasdaq on Oct 30, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Penumbra headlines
- Penumbra, Inc. Reports Third Quarter 2026 Revenue of $410.1 millionPenumbra, Inc. reported revenue of $410.1 million for the third quarter of 2026, representing an increase of 15.6% compared to the third quarter of 2025. The company's global thrombectomy revenue…Nasdaq
- Penumbra Inc. Q3 Income Drops(RTTNews) - Penumbra Inc. (PEN) released a profit for third quarter that Dropped, from the same period last yearNasdaq
- Penumbra, Inc. Reports Third Quarter 2026 Financial ResultsALAMEDA, Calif., Oct. 29, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the third quarter ended September 30, 2026.…PR Newswire
- IART vs. PEN: Which Stock Is the Better Value Option?IART vs. PEN: Which Stock Is the Better Value Option?NasdaqIART, PEN
- IART or PEN: Which Is the Better Value Stock Right Now?IART vs. PEN: Which Stock Is the Better Value Option?NasdaqIART, PEN
- Reasons to Retain Penumbra Stock in Your Portfolio for NowPEN's portfolio expansion and international growth support momentum, while rising costs, FX exposure and margin pressure remain key risks.NasdaqPEN, TFX, GMED, VCYT
- TFX vs. PEN: Which Stock Is the Better Value Option?TFX vs. PEN: Which Stock Is the Better Value Option?NasdaqTFX, PEN
- Notable Wednesday Option Activity: ZVRA, KOD, PENLooking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Zevra Therapeutics, Inc (Symbol: ZVRA), where a total volume of 8,827 contracts…NasdaqZVRA, KOD, PEN
- TFX or PEN: Which Is the Better Value Stock Right Now?TFX vs. PEN: Which Stock Is the Better Value Option?NasdaqTFX, PEN
- TFX vs. PEN: Which Stock Is the Better Value Option?TFX vs. PEN: Which Stock Is the Better Value Option?NasdaqTFX, PEN
- Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising costs and execution risks keep the buy case uncertain.NasdaqANGO, BSX, PEN
- Penumbra GAAP EPS of $0.88, revenue of $390MSeeking Alpha
- Penumbra Inc. Q2 Income Falls(RTTNews) - Penumbra Inc. (PEN) announced a profit for second quarter that Dropped, from last yearNasdaq
- 3 Medical Device Stocks Giving Investors a Different Healthcare PlayWhen investors think of the health care sector, most imagine the stability of pharmaceutical giants or the high-risk/high-reward profile of up-and-coming clinical stage drug developers. Medical…NasdaqGMED, INSP, PEN
- IQV vs. PEN: Which Stock Is the Better Value Option?IQV vs. PEN: Which Stock Is the Better Value Option?NasdaqIQV, PEN
- GMED vs. PEN: Which Stock Should Value Investors Buy Now?GMED vs. PEN: Which Stock Is the Better Value Option?NasdaqGMED, PEN
- Penumbra Receives CE Nod for THUNDERBOLT: Stock to Gain?PEN gains CE Mark in Europe for THUNDERBOLT, expanding stroke treatment access and advancing its global stroke care strategy.NasdaqIART, GMED, PAHC, PEN
- ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?ClearPoint Neuro (CLPT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price…NasdaqCLPT, PEN
- GMED or PEN: Which Is the Better Value Stock Right Now?GMED vs. PEN: Which Stock Is the Better Value Option?NasdaqGMED, PEN
- Boston Scientific: Adding Another Growth Engine With PenumbraSeeking AlphaPEN, BSX
- Boston Scientific's Bet On Penumbra Isn't To My LikingSeeking Alpha
- Boston Scientific Acquiring Penumbra Was The Logical Next StepSeeking AlphaPEN, BSX
- Penumbra, Inc. (PEN) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha
- Penumbra: Well-Placed For Above-Average Growth, But Mind The VolatilitySeeking Alpha
- Penumbra, Inc. (PEN) Presents at Piper Sandler 37th Annual Healthcare Conference TranscriptSeeking Alpha
- Penumbra, Inc. (PEN) Q3 2025 Earnings Call TranscriptSeeking Alpha
- Penumbra, Inc. (PEN) Presents at Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 TranscriptSeeking Alpha
- Analysts See 12% Upside For JMOMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price,…NasdaqJMOM, LLYVK, PEN, UBER
- Penumbra, Inc. (PEN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking AlphaPEN, MS
- Penumbra, Inc. (PEN) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptSeeking Alpha
- Penumbra, Inc. (PEN) Q2 2025 Earnings Call TranscriptSeeking Alpha
- Penumbra: AI Meets Aspiration - Why The Stock Is A Structural WinnerSeeking Alpha